MX2009009020A - Uso de riboflavina en el tratamiento de la hipertension. - Google Patents
Uso de riboflavina en el tratamiento de la hipertension.Info
- Publication number
- MX2009009020A MX2009009020A MX2009009020A MX2009009020A MX2009009020A MX 2009009020 A MX2009009020 A MX 2009009020A MX 2009009020 A MX2009009020 A MX 2009009020A MX 2009009020 A MX2009009020 A MX 2009009020A MX 2009009020 A MX2009009020 A MX 2009009020A
- Authority
- MX
- Mexico
- Prior art keywords
- riboflavin
- treatment
- hypertension
- provides
- subject
- Prior art date
Links
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 title abstract 8
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 title abstract 4
- 229960002477 riboflavin Drugs 0.000 title abstract 4
- 235000019192 riboflavin Nutrition 0.000 title abstract 4
- 239000002151 riboflavin Substances 0.000 title abstract 4
- 238000011282 treatment Methods 0.000 title abstract 4
- 206010020772 Hypertension Diseases 0.000 title 1
- 101000587058 Homo sapiens Methylenetetrahydrofolate reductase Proteins 0.000 abstract 2
- 102100029684 Methylenetetrahydrofolate reductase Human genes 0.000 abstract 2
- 230000036772 blood pressure Effects 0.000 abstract 2
- 238000011321 prophylaxis Methods 0.000 abstract 2
- 239000002220 antihypertensive agent Substances 0.000 abstract 1
- 229940030600 antihypertensive agent Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 229940127557 pharmaceutical product Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0703514.0A GB0703514D0 (en) | 2007-02-23 | 2007-02-23 | Use of riboflavin |
| PCT/EP2008/001437 WO2008101724A1 (en) | 2007-02-23 | 2008-02-22 | Use of riboflavin in the treatment of hypertension |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2009009020A true MX2009009020A (es) | 2010-02-17 |
Family
ID=37945596
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2009009020A MX2009009020A (es) | 2007-02-23 | 2008-02-22 | Uso de riboflavina en el tratamiento de la hipertension. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20100324019A1 (enExample) |
| EP (1) | EP2139488B1 (enExample) |
| JP (1) | JP5577100B2 (enExample) |
| CN (1) | CN101678030B (enExample) |
| CA (1) | CA2679217C (enExample) |
| EA (1) | EA019281B1 (enExample) |
| ES (1) | ES2393144T3 (enExample) |
| GB (1) | GB0703514D0 (enExample) |
| MX (1) | MX2009009020A (enExample) |
| WO (1) | WO2008101724A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104737023B (zh) * | 2012-08-16 | 2017-07-28 | 重症监护诊断股份有限公司 | 预测患高血压风险的方法 |
| CN103721259A (zh) * | 2014-01-07 | 2014-04-16 | 深圳奥萨医药有限公司 | 血管紧张素ⅱ受体阻断剂/噻嗪类利尿剂/5-甲基四氢叶酸药物组合物 |
| CN109295216A (zh) * | 2018-11-06 | 2019-02-01 | 宁波艾捷康宁生物科技有限公司 | 预测高血压个体化药物药效的snp位点和检测试剂盒 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4264601A (en) * | 1979-06-12 | 1981-04-28 | The Board Of Regents Of The University Of Oklahoma | Antihypertensive agents and their use in treatment of hypertension |
| DE3682208D1 (de) * | 1986-12-18 | 1991-11-28 | Kurt Heinz Bauer | Gegenueber lichteinfluss stabilisiertes nifedipin-konzentrat und verfahren zu seiner herstellung. |
| US6485959B1 (en) * | 1998-10-07 | 2002-11-26 | Cedars Sinai Medical Center | Cell preconditioning and cryopresevation medium |
| CN1136895C (zh) * | 2001-05-24 | 2004-02-04 | 魏振鸣 | 一种治疗冠心病的药物 |
| WO2006085128A1 (en) * | 2005-02-09 | 2006-08-17 | Wockhardt Limited | Cardiovascular therapeutic combinations |
| US7838526B2 (en) * | 2005-08-05 | 2010-11-23 | Esther Baldinger | Method of treating neurological disorders |
-
2007
- 2007-02-23 GB GBGB0703514.0A patent/GB0703514D0/en not_active Ceased
-
2008
- 2008-02-22 EA EA200901145A patent/EA019281B1/ru not_active IP Right Cessation
- 2008-02-22 EP EP08715988A patent/EP2139488B1/en not_active Not-in-force
- 2008-02-22 WO PCT/EP2008/001437 patent/WO2008101724A1/en not_active Ceased
- 2008-02-22 MX MX2009009020A patent/MX2009009020A/es active IP Right Grant
- 2008-02-22 CA CA2679217A patent/CA2679217C/en active Active
- 2008-02-22 CN CN2008800135209A patent/CN101678030B/zh not_active Expired - Fee Related
- 2008-02-22 JP JP2009550246A patent/JP5577100B2/ja not_active Expired - Fee Related
- 2008-02-22 US US12/528,105 patent/US20100324019A1/en not_active Abandoned
- 2008-02-22 ES ES08715988T patent/ES2393144T3/es active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20100324019A1 (en) | 2010-12-23 |
| CA2679217A1 (en) | 2008-08-28 |
| EP2139488A1 (en) | 2010-01-06 |
| EA019281B1 (ru) | 2014-02-28 |
| GB0703514D0 (en) | 2007-04-04 |
| CN101678030B (zh) | 2013-06-05 |
| EP2139488B1 (en) | 2012-08-15 |
| CN101678030A (zh) | 2010-03-24 |
| WO2008101724A1 (en) | 2008-08-28 |
| EA200901145A1 (ru) | 2010-02-26 |
| JP2010519235A (ja) | 2010-06-03 |
| WO2008101724A8 (en) | 2009-10-08 |
| CA2679217C (en) | 2016-05-17 |
| JP5577100B2 (ja) | 2014-08-20 |
| ES2393144T3 (es) | 2012-12-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2007146426A3 (en) | Nanoshells for drug delivery | |
| CA2963423A1 (en) | Device and method for delivery of a medicament | |
| WO2008021113A3 (en) | Transdermal methods and systems for treating alzheimer's disease | |
| WO2010042471A3 (en) | Medical devices for delivery of therapeutic agents to body lumens | |
| MY147393A (en) | Administration of dipeptidyl peptidase inhibitors | |
| WO2008085765A3 (en) | Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain | |
| WO2008039218A3 (en) | Inhibitors of bruton's tyrosine kinase | |
| IL206296A (en) | History of aminopyrazole, and their medicinal products and their use in the preparation of drugs for the prevention and treatment of diseases | |
| UA97795C2 (uk) | Дейтеровані похідні катехоламіну і медикаменти, що містять згадані сполуки | |
| WO2006060507A3 (en) | Compositions comprising immunomodulatory compounds and the use thereof for the treatment of immunodeficiency disorders | |
| WO2009105432A3 (en) | Devices and methods for delivery of a therapeutic agent through a pneumostoma | |
| TW200631578A (en) | Methods and compositions using immunomodulatory compounds for treatment and management of central nervous system injury | |
| MX2009004561A (es) | Derivados de pirazolilo con actividad analgesica y utiles en el tratamiento o profilaxis del dolor. | |
| MX2008011633A (es) | Aminoquinolonas como inhibidores de gsk-3. | |
| AR060019A1 (es) | Composicion farmaceutica, producto y metodo de tratamiento para un trastorno cognitivo y usos de un inhibidor de acetilcolinesterasa y un antagonista de 5- ht6 en la fabricacion de un medicamento para el tratamiento de un trastorno cognitivo | |
| WO2010045417A3 (en) | Combination therapies for the treatment of obesity | |
| MX2007006066A (es) | Inhibidores de jnk para el tratamiento de lesiones del snc. | |
| WO2010151503A3 (en) | Combination therapies for the treatment of obesity | |
| MX2010002667A (es) | Cianoaminoquinolonas y tetrazoloaminoquinolonas como inhibidores de gsk-3. | |
| WO2007062093A3 (en) | Combination therapy for the treatment of cancer comprising a metalloprotease inhibitor | |
| TW200642704A (en) | Oral drug delivery system and methods of use thereof | |
| MX2010010334A (es) | Tratamiento de psoriasis o artritis psoriatica utilizando ciclopropil-n-{2-{(1s)-1-(3-etoxi-4-metoxifenil)-2-(metilsulfonil )etil]-3-oxoisoindolina-4-il}carboxamida. | |
| GB2446341A (en) | Method and system for transdermal drug delivery | |
| MX2009009020A (es) | Uso de riboflavina en el tratamiento de la hipertension. | |
| NZ602807A (en) | 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]-1h-quinolin-2-one and an mtor inhibitor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration | ||
| GB | Transfer or rights |